Abbott Laboratories

$122.56 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Join the waitlist

About Abbott Laboratories

Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Company focuses on cardiovascular, diabetes care, diagnostics, neuromodulation, nutrition and medicine. It offers products, including FreeStyle, PediaSure, Pedialyte, Similac, EleCare, ZonePerfect, Juven, Ensure and Glucerna. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. The cardiovascular's products include Portico, MitraClip, Dilatation Catheter, among others. The diagnostics products include IntelliFISH, Vysis ALK, STARLIMS, PathVysion, AlinIQ, among others.

Stock Analysis

last close $119.78
1-mo return 3.6%
3-mo return 7.3%
avg daily vol. 5.14M
52-week high 128.54
52-week low 83.52
market cap. $210.7B
forward pe 23.7
annual div. 1.8
roe 14.1%
ltg forecast 15.6%
dividend yield 1.5%
annual rev. $34.6B
inst own. 75.8%

Join the waitlist for early access and a chance to earn $50 in free stock

Join the waitlist